Organigram Global Inc.
OGI Nasdaq
SEC CIK 1620737
Follow Organigram Global
Weekly email: filings, results
Revenue, last year
CAD 159.8M
+0% vs prior year
Net income
−CAD 45.4M
+0% vs prior year
EPS, diluted
−CAD 0.48
+0% vs prior year
Operating cash flow
CAD 3.9M
+0% vs prior year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | CAD 159.8M | −CAD 45.4M |
| FY24 | CAD 159.8M | −CAD 45.4M |
| FY23 | - | - |
| FY22 | CAD 145.8M | −CAD 14.3M |
| FY21 | CAD 79.2M | −CAD 130.7M |
| FY20 | CAD 86.8M | −CAD 136.2M |
| FY19 | CAD 80.4M | −CAD 9.5M |
| FY18 | CAD 12.4M | CAD 20.5M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 29.7% | −22.3% | −28.4% |
| FY24 | 29.7% | −22.3% | −28.4% |
| FY23 | - | - | - |
| FY22 | 21.7% | −29.6% | −9.8% |
| FY21 | −35.9% | −116% | −165.1% |
| FY20 | −65.1% | −167.6% | −156.9% |
| FY19 | 60.3% | 6.8% | −11.9% |
| FY18 | 55.5% | 293% | 165% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −CAD 859K |
| FY24 | −CAD 859K |
| FY23 | - |
| FY22 | −CAD 85M |
| FY21 | −CAD 40.3M |
| FY20 | −CAD 122.3M |
| FY19 | −CAD 143.8M |
| FY18 | −CAD 69.1M |
| FY17 | - |
- Organigram Global
- Healthcare median
Show the numbers
| Year | Organigram Global | Healthcare median |
|---|---|---|
| FY25 | −28.4% | −30.6% |
| FY24 | −28.4% | −47% |
| FY23 | - | −58% |
| FY22 | −9.8% | −80.4% |
| FY21 | −165.1% | −71.8% |
| FY20 | −156.9% | −62.2% |
| FY19 | −11.9% | −46.2% |
| FY18 | 165% | −49.6% |
| FY17 | - | −45.9% |